July 26, 2017. Thank you for the opportunity to speak today. My name is Dr. Megan Polanin. I am a Senior Fellow at the National Center for Health Research.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
Here are our Statements and Positions on issues that affect you.
NCHR Comments on CPSC Agenda and Priorities for FY2018/2019
July 26, 2017. Two priorities that are clearly consistent with CPSC priorities are the safety of children’s products. We are very concerned about exposures to phthalates in children’s toys and other products as well as endocrine-disrupting chemicals and other safety concerns related to recycled tire crumb rubber and other artificial turf (including “poured in place” surfaces).
Read More »National Center for Health Research’s Public Comments on the USPSTF’s Draft Research Plan for Tobacco and Nicotine Use Prevention in Children and Adolescents: Primary Care Interventions
July 21, 2017. In conclusion, we support many of the methodological proposals included in USPSTF’s draft research plan to study the impact of interventions to prevent and reduce tobacco and nicotine use in children and adolescents. However, the draft approach would not evaluate the effectiveness of specific types of interventions on subgroups of children and adolescents. We strongly recommend making the above changes to strengthen the utility of the research findings that USPSTF will rely on for its recommendations.
Read More »NCHR Letter to Mayor Bowser Regarding Toxic Artificial Turf
July 19, 2017. As our mayor, I urge you to safeguard our children and athletes by requiring safer athletic fields and playgrounds. At this point, there are no synthetic materials that are proven to be as safe as natural grass.
Read More »NCHR Testimony at FDA on the Hatch-Waxman Amendments
July 18, 2017. We hope FDA will follow the Commissioner’s recommended course of action to further improve this system for the future benefit of patients and industry alike.
Read More »